Table 1.
apo–LmrR | LmrR–drug complexes | ||
---|---|---|---|
H33342 | Daunomycin | ||
Data analysis | |||
Space group | C2221 | P43212 | P212121 |
Unit cell (Å) | |||
a | 46.6 | 34.9 | 35.4 |
b | 52.6 | 34.9 | 53.0 |
c | 174.9 | 197.0 | 147.1 |
Resolution (Å) | 35–2.0 | 65–2.2 | 70–2.2 |
Rmergea | 0.04 (0.5)b | 0.05 (0.206) | 0.036 (0.273) |
Mean I/σI | 46.6 (2.0) | 21.1 (4.8) | 28.9 (3.8) |
Completeness (%) | 100 (99.3) | 99.8 (99.0) | 96.0 (99.9) |
Unique reflections | 15 006 | 6948 | 17 020 |
Redundancy | 6.7 (7.8) | 3.9 (2.9) | 3.0 (3.5) |
Refinement statistics | |||
Resolution (Å) | 23–2.0 | 50–2.2 | 50–2.2 |
Rwork/Rfreec | 0.22/0.27 | 0.21/0.26 | 0.23/0.27 |
No. of non-H atoms | |||
Protein | 1693 | 850 | 1834 |
Ligand | — | 34 | 38 |
Waters | 83 | 27 | 43 |
Root mean square deviations in | |||
Bond length (Å) | 0.011 | 0.013 | 0.016 |
Bond angles (deg) | 1.4 | 0.9 | 0.7 |
Average B-values (Å2) | |||
Protein | 15 | 21 | 23 |
Ligand | — | 34 | 73 |
Ramachandran analysis | |||
Most favoured (%) | 99.0 | 98.0 | 98.0 |
Additional allowed (%) | 1.0 | 2.0 | 2.0 |
aRmerge=ΣΣ∣Ihkl−Ihkl(j)∣/ΣΣIhkl, where Ihkl(j) is the observed intensity and Ihkl is the final average intensity value. | |||
bValues in parentheses are for the highest resolution shell. | |||
cRwork=Σ∣∣Fobs∣−∣Fcalc∣∣/Σ∣Fobs∣ and Rfree=Σ∣∣Fobs∣−∣Fcalc∣∣/Σ∣Fobs∣, where all reflections belong to a test set of 10% randomly selected data. |